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Introduction {#sec1}
============

C-terminal binding protein 1 (CtBP1) is a ubiquitously expressed dual-function protein that acts as a transcriptional corepressor in the cell nucleus and as a regulator of membrane fission in the cytoplasm ([@bib5], [@bib60]). It is expressed in most types of neurons, where it shows a distinct localization to nuclei and presynapses ([@bib22], [@bib57]). Presynaptic CtBP1 is localized near the active zone via its direct binding to two large, highly homologous active zone scaffolding proteins: bassoon (Bsn) and piccolo (Pclo) ([@bib26], [@bib57]). A dynamic synapto-nuclear shuttling of CtBP1, induced by changes in its affinity to Bsn and regulated by neuronal activity and cellular NAD/NADH ratio was shown to control the expression of a variety of neuroplasticity-related genes ([@bib26], [@bib27]). Although the importance of CtBP1-dependent transcriptional regulation of neuroplasticity genes emerged from recent studies ([@bib14], [@bib26], [@bib27]), the role of synaptic CtBP1 is still elusive. Here, we hypothesize that, in addition to being implicated in the remote control of gene expression, synaptic CtBP1 might directly contribute to neurotransmitter release and SV recycling. The involvement of CtBP1 in various membrane fission processes at the Golgi and plasma membrane in non-neuronal cells is in support of this view ([@bib60]). Although the mechanism of CtBP1-mediated fission remains controversial, an increasing body of evidence suggests that it induces formation of vesicular carriers by recruiting and orchestrating numerous enzymes that promote local lipid reorganization leading to membrane bending ([@bib60]). This is mechanistically distinct from the principle of torsional force used in dynamin-mediated fission, most commonly implied in SV recycling ([@bib1], [@bib50]). Despite the well-established role of dynamin in SV fission, recent findings suggest that dynamin-independent forms of endocytosis might occur at hippocampal synapses ([@bib13], [@bib62]). Moreover, a crosstalk and cooperativity between dynamin-mediated fission, actin cytoskeleton-mediated vesicle reformation and lipid reorganization by lipid-modifying enzymes in the execution of SV recycling were recently suggested ([@bib45], [@bib54], [@bib63]).

In this study, we investigated the potential role of synaptic CtBP1 in the regulation of SV fusion and recycling. Using knockdown (KD), knockout (KO), and complementation approaches, we demonstrate that loss of nuclear CtBP1 expression increases synaptogenesis and the release probability of SVs, whereas the depletion of synaptic CtBP1 leads to defects in SV retrieval, accompanied by an enlargement of the docked synaptic vesicles and pronounced synaptic depression during sustained neurotransmission. Functional experiments and super-resolution imaging indicate that synaptic CtBP1 acts at the same membrane domain as dynamin to promote SV recycling. Our results revealed a crucial requirement for CtBP1-mediated membrane fission and the activity of Phospholipase D1 (PLD1) in this process. Finally, we show that CtBP1 phosphorylation by the signaling kinase p21 (RAC1) activated kinase 1 (Pak1) provides a molecular switch controlling its re-distribution from the active zone protein Bsn to the endocytic effector PLD1, thus fine tuning its membrane trafficking activity and potentially linking presynaptic exo- and endocytic processes.

Results {#sec2}
=======

CtBP1 Contributes to Synaptic Vesicle Retrieval and Regulates the Size of the Total Recycling Pool {#sec2.1}
--------------------------------------------------------------------------------------------------

To assess whether the absence of CtBP1 affects synaptic structure and function, we used a previously established RNA-interference approach in cultured hippocampal neurons ([@bib26]). Significant downregulation of CtBP1, but no obvious differences in the morphology and the expression of pre- and post-synaptic markers or CtBP2, a close homolog of CtBP1, were observed between controls expressing scrambled short hairpin RNA (shRNA) (scr) and CtBP1 knockdown (CtBP1KD) neurons expressing target shRNAs: CtBP1KD944 or CtBP1KD467 ([Figures 1](#fig1){ref-type="fig"}A, 1B, and [S1](#mmc1){ref-type="supplementary-material"}A--S1D). Likewise, no regulation of synaptic proteins and CtBP2 was observed in homogenates or P2 fractions obtained from brains of *CtBP1* knockout animals ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). To assess SV turnover in the absence of CtBP1, we applied a fluorophore-coupled antibody recognizing the lumenal domain of the integral SV protein synaptotagmin 1 (Syt1 Ab) to living neurons. Syt1 Ab binds to its epitope, which is transiently accessible upon SV fusion with the plasma membrane until its internalization during compensatory endocytosis. The fluorescence intensity of the internalized Syt1 Ab provides an estimate of SV recycling at individual synapses ([@bib34], [@bib36]). The Syt1 Ab uptake driven by endogenous activity (network activity-driven release) was reduced by about 50% in CtBP1KD neurons as compared with controls (30-min incubation; [Figures 1](#fig1){ref-type="fig"}C and 1D). To address the potential contribution of an increased neuronal network activity to this phenotype and isolate presynaptic effects, we also measured the spontaneous (i.e., action-potential-independent) SV recycling within 30 min in the presence of TTX and the pool of all fusion-competent vesicles (total recycling pool \[TRP\]) upon brief depolarization with 50 mM KCl. In both conditions, Syt1 Ab uptake was strongly reduced (∼50%) in CtBP1KD ([Figure 1](#fig1){ref-type="fig"}C), indicating an impairment in both evoked and spontaneous SV recycling at CtBP1-deficient synapses.Figure 1KD of CtBP1 Reduces SV Recycling(A) Representative images showing that the general neuronal morphology and the localization of synaptic markers are not changed in CtBP1KD neurons.(B) Representative western blots of samples from rat neurons transduced with viruses expressing shRNAs: scr, CtBP1KD944, and KD467, together with sypHy. The immunoreactivity for CtBP1 and CtBP2 and TCE total protein stain used as a loading control are shown. Although a notable downregulation of CtBP1 is evident in KD samples compared with scr, no changes were detected for CtBP2.(C) Quantification of the Syt1 Ab uptake, driven by basal network activity, depolarization with 50 mM KCl, or in the presence of 1 μM TTX in scr, and KD cultures.(D) Representative images of Syt1 Ab uptake, driven by basal neuronal network activity in control (scr) and CtBP1KD944 and CtBP1KD467 cultures.(E) Representative images of neurons expressing sypHy used to determine SV pool sizes. Cells were imaged in the presence of bafilomycin A1 during stimulation with 40 APs at 20 Hz to release RRP. After a rest for 2 min, a train of 200 APs at 20 Hz triggered the exocytosis of all release-competent vesicles (TRP). A final NH~4~Cl pulse, which visualized all released and non-released sypHy-positive vesicles (total pool: TP), was used for normalization.(F) Average sypHy-fluorescence (FsypHy) traces reporting SV pool sizes from control and CtBP1KD neurons. RRP and TRP are given as fractions of TP.(G) The mean values of RRP in scr, CtBP1KD944, and CtBP1KD467 did not differ significantly, but the KD of CtBP1 led to a significant reduction in TRP size.(H) Images of sypHy showing SV exo-endocytosis at synapses in response to 200 APs at 5 Hz. The top image shows the reference (F) of tdimer 2 before stimulation and the bottom three panels show the green (F) of sypHy before, during, and after the stimulation.(I--K) CtBP1 depletion results in slower retrieval of exocytosed SV. Peak-normalized sypHy responses to 200 APs at 5 Hz (I), 200 APs at 20 Hz (J), and 200 APs at 40 Hz (K), and respective single exponential fits of fluorescence decay are shown for each group. The estimated half times of endocytosis (t~1/2~) are plotted.Overlays are shown in the indicated colors. Scale bars: 10 μm in (A); 5 μm in (D), (E), and (H).In the plots the interquartile range and median are depicted as boxes, minimal and maximal values as whiskers and + indicates mean. In the graphs comparisons with the control are indicated above each box and, comparisons between the conditions are given as horizontal bars. Significance is indicated using asterisks: nsP \> 0.05, ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001, ∗∗∗∗ p \< 0.0001.

To monitor SV recycling by an alternative approach, we expressed scr and CtBP1KD944 and CtBP1KD467 from a bicistronic vector together with ratio-sypHy (sypHy) ([Figure 1](#fig1){ref-type="fig"}E). SypHy is an indicator composed of the SV protein synaptophysin 1 fused to pH-sensitive GFP in one of the luminal domains and tdimer 2 in the cytoplasmic domain, which allows its visualization before stimulation ([@bib15], [@bib52]). The fluorescence of sypHy increases upon SV exocytosis and decays after SV endocytosis and re-acidification. To determine the sizes of the readily releasable pool (RRP) and the recycling pool (RP), we used bafilomycin A1, a blocker of the vesicular proton pump that prevents the re-acidification of endocytosed SVs and thus the decline of sypHy fluorescence ([@bib4]). Exocytosis of the SVs from RRP and RP was evoked by the sequential delivery of 40 and 200 action potentials (APs) at 20 Hz ([Figures 1](#fig1){ref-type="fig"}E--1G). In CtBP1KD neurons, around 14% of the sypHy-positive SVs fused upon stimulation with 40 APs at 20 Hz (i.e., RRP), which was comparable to control neurons. The delivery of an additional 200 APs triggered exocytosis of ∼50% of all sypHy-labeled SVs in controls, but only ∼30% in CtBP1KD neurons, indicating a role of CtBP1 in the control of TRP (comprising RRP and RP). Alkalization with ammonium chloride, which de-quenches all sypHy-positive SVs, revealed no differences in its expression between CtBP1KD and control neurons. ([Figures 1](#fig1){ref-type="fig"}E--1G) An analogous analysis performed in cultured neurons isolated from constitutive *Ctbp1* KO mice recapitulated the results of the KD approach and confirmed the significant reduction of TRP in CtBP1-deficient synapses ([Figures S2](#mmc1){ref-type="supplementary-material"}C--S2E).

To assess potential changes in the kinetics of SV exo-endocytosis in the absence of CtBP1, we monitored sypHy responses evoked by a train of 200 APs at 5, 20, or 40 Hz in neurons expressing CtBP1KD944, CtBP1KD467, or scrambled shRNA ([Figures 1](#fig1){ref-type="fig"}H--1K). Several stimulation rates were tested because distinct molecular mechanisms have been proposed to mediate SV retrieval at different stimulation frequencies ([@bib7], [@bib31], [@bib54]). Although the time course of exocytosis was indistinguishable between CtBP1KD and control groups, the sypHy fluorescence decay was significantly slower in CtBP1KD neurons at all frequencies tested ([Figures 1](#fig1){ref-type="fig"}I--1K), suggesting a role for CtBP1 in SV endocytosis. Analogous experiments in cultured neurons from constitutive *Ctbp1* KO mice confirmed that conclusion ([Figure S2](#mmc1){ref-type="supplementary-material"}G). Taken together, these results suggest that CtBP1 contributes to SV retrieval at a broad range of neuronal firing frequencies and is specifically required for maintaining the size of TRP during sustained neuronal activity.

Deletion of CtBP1 Induces Changes in SV Size and Distribution {#sec2.2}
-------------------------------------------------------------

Next, we performed an ultrastructural analysis of small glutamatergic spine synapses in 4--5-week-old cultured hippocampal slices obtained from *Ctbp1* KO mice and their wild-type (WT) siblings. A combination of rapid cryo-fixation, automated freeze substitution, and 3D-electron tomographic analysis was designed to accurately reveal vesicular organization at presynaptic active zones (AZs) with nanometer precision and to circumvent the introduction of morphological artifacts associated with conventional electron microscopy preparation methods requiring dehydration of the tissue at room temperature ([@bib67]; [@bib68]). An analysis of gross synaptic morphology and the number of SVs in individual presynaptic glutamatergic terminals revealed no differences between *Ctbp1* KO and WT synaptic profiles ([Figures 2](#fig2){ref-type="fig"}A--2G). Electron tomographic analysis, however, revealed changes in the distribution of SVs in KO versus WT synapses ([Figures 2](#fig2){ref-type="fig"}H--2K). The KO synaptic profiles showed a significant increase in the number of membrane-proximal SVs (within 0--5, 0--40, 50--100, and 0--100 nm of the AZs; [Figures 2](#fig2){ref-type="fig"}L and 2P; [Table S1](#mmc1){ref-type="supplementary-material"}). It is important to note that no statistically significant differences in the number of vesicles within 0--2 nm of the AZs were observed ([Figure 2](#fig2){ref-type="fig"}M), which is the morphological correlate of RRP. Analyses of individual SVs revealed a small, but significant, increase in the diameter of docked SVs ([Figure 2](#fig2){ref-type="fig"}O); however, no change in SV size was seen when comparing all synaptic vesicles within 0--200 nm ([Table S1](#mmc1){ref-type="supplementary-material"}). Altogether, these data suggest that loss of CtBP1 does not affect the overall number of SVs in the presynaptic terminals but, rather, triggers their redistribution from membrane-distal to membrane-proximal areas. They also indicate that CtBP1 regulates the size uniformity of docked SVs.Figure 2Ultrastructural Analysis of Synaptic Morphology and SV Distribution in Synaptic Profiles of Glutamatergic Spine Synapses in High-Pressure, Frozen, and Freeze-Substituted Hippocampal Organotypic Slice Cultures of WT and *Ctbp1* KO mice(A and B) Electron micrographs of WT (A) and respective *Ctbp1* KO (B) synaptic profiles.(C--G) Mean values for the number of SVs per synaptic profile (C), SV density (D), postsynaptic density (PSD) length (E), number of endosomes per synaptic profile (F), and number of large dense-core vesicles (LDCVs) per synaptic profile (G).(H and I) Electron tomography sub-volumes of WT (H) and *Ctbp1* KO (I) synapses.(J and K) 3D models of synaptic profiles in WT (J) and *Ctbp1* KO (K), including orthogonal views of the AZ (white), docked SVs (red), and nonattached SVs (gray).(L--P) Graphs show spatial distribution of SVs within 100 nm of the AZ (L), mean number of docked SVs (within 0--2 nm of the AZ) per AZ area (M), frequency distribution of SV diameters within 200 nm of the AZ (N), mean diameter of docked SVs (O), and mean number SV within 0--40 nm of the AZ (P) per AZ area.KO and WT animals were analyzed in electron micrographs of 60-nm-thick, ultrathin sections (A--G) and by 3D electron tomography (H--P). Scale bars: 200 nm in (B); 100 nm in (I).In the plots the interquartile range and median are depicted as boxes, minimal and maximal values as whiskers and + indicates mean. In Figures 2F and 2G scatter dot plots show mean and 95% CI, and in 2 L and N bars indicate mean and SEM. Significance is indicated using asterisks: ∗p \< 0.05, ∗∗p \< 0.01.

Distinct Roles of Nuclear and Synaptic CtBP1 in Neurotransmission {#sec2.3}
-----------------------------------------------------------------

Since we observed changes in the diameter of docked SVs and the size of the TRP, we next determined the effect of CtBP1 depletion on neurotransmission. We first compared the AP-evoked excitatory postsynaptic currents (EPSCs) in cultures of autaptic hippocampal neurons transduced with CtBP1KD944 shRNA or scr as a control. Unexpectedly, CtBP1KD944 neurons exhibited greater amplitudes of EPSCs compared with controls ([Figure 3](#fig3){ref-type="fig"}A). To examine whether the increase in EPSC amplitude reflected an increase in the amount of glutamate loaded into SVs or changes in postsynaptic receptors, we analyzed miniature EPSCs (mEPSCs), which represent single-fusion events. Neither the amplitudes nor the charges of mEPSCs were affected by CtBP1-depletion, indicating that the observed increase in EPSC amplitude cannot be attributed to any major changes in vesicular neurotransmitter content or postsynaptic properties ([Figures 3](#fig3){ref-type="fig"}B and 3C; [Table S2](#mmc1){ref-type="supplementary-material"}). In support of the latter conclusion, quantitative, live immunolabeling of autaptic neurons with an antibody recognizing the extracellular epitope of GluAs did not uncover any significant differences in the surface expression of AMPA receptors between the groups ([Figures 3](#fig3){ref-type="fig"}E and 3F). The mEPSC frequency was not significantly altered in CtBP1944KD neurons ([Figure 3](#fig3){ref-type="fig"}D). However, the number of morphological synapses assessed as a number of co-localizing synapsin-GluA puncta in CtBP1KD944 neurons was slightly higher, suggesting increased synaptogenesis in the absence of CtBP1 ([Figures 3](#fig3){ref-type="fig"}E and 3G). The increased synapse number might contribute, at least in part, to the increase of EPSC amplitude observed in these neurons.Figure 3Synaptic and Nuclear CtBP1 Have Distinct Effects on Neurotransmission and Their Deletion Leads to Pronounced Short-Term Depression(A) Averaged normalized evoked EPSC amplitudes from control, CtBP1KD944, EGFP-CtBP1, and YFP-CtBP2(NLS)-CtBP1 expressed in CtBP1KD944 neurons.(B) Example traces showing spontaneous EPSCs from control, CtBP1KD944 neurons, or neurons expressing EGFP-CtBP1 and YFP-CtBP2(NLS)-CtBP1 on CtBP1KD background.(C) Respective quantifications of average mEPSC amplitudes from the groups shown in (B).(D) Respective quantifications of mEPSC frequency from the groups shown in (B).(E) Autaptic neurons expressing the scr and CtBP1KD944 shRNA or the rescue variants: EGFP-CtBP1 or YFP-CtBP2(NLS)-CtBP1 on CtBP1KD944 background were live stained for surface AMPA receptors and post-fixation for synapsin to label presynapses. The overlays are shown in the indicated colors. Scale bar: 5 μm.(F and G) Quantification of the experiment in (E). Immunofluorescence (IF) intensity of surface-expressed GluA at synapses does not differ among conditions (F), but CtBP1KD944 and expression of EGFP-CtBP1 in CtBP1KD944 neurons increase the number of synapses (G).(H and I) Typical responses to application of 500-m OsmM sucrose for 10 s (H) and average, normalized sizes of RRP (I).(J and K) Averaged, normalized vesicular release probability (J) and PPR (K) in control, CtBP1KD944, and EGFP-CtBP1 and YFP-CtBP2(NLS)-CtBP1 expressed in CtBP1KD944 neurons.(L) Averaged, normalized amplitudes of EPSC evoked by a train of stimuli at 10 Hz.In the plots the interquartile range and median are depicted as boxes, minimal and maximal values as whiskers and + indicates mean. Data points in the curve in [Figures 3](#fig3){ref-type="fig"}L are depicted as means and SEM. In the graphs comparisons with the control are indicated above each box and, comparisons between the conditions are given as horizontal bars. Significance is indicated using asterisks: nsP \> 0.05, ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001, ∗∗∗∗ p \< 0.0001.

Next, we measured the postsynaptic current evoked by application of hypertonic sucrose, leading to the release of all docked SVs (RRP) ([@bib53]). We detected unchanged sucrose-evoked currents ([Figures 3](#fig3){ref-type="fig"}H and 3I), which is in line with unchanged RRP measured by sypHy imaging ([Figures 1](#fig1){ref-type="fig"}E--1G) and with the unchanged number of morphologically docked SVs at CtBP1-deficient synapses ([Figure 2](#fig2){ref-type="fig"}M). The unchanged total RRP charge, but a significantly higher EPSC charge evoked by an injection of a single AP, implies increased mean vesicular release probability (Pvr; [Figure 3](#fig3){ref-type="fig"}J; [Table S2](#mmc1){ref-type="supplementary-material"}). Increased Pvr is predictive of increased synaptic transmission upon isolated stimuli but leads to enhanced short-term depression upon repeated stimulation. To explore that possibility, we recorded synaptic responses induced by a 25-ms spaced pair of APs ([Figure 3](#fig3){ref-type="fig"}K). In line with the elevated Pvr, the paired pulse ratio (PPR) (i.e., the ratio of the peak amplitude of the second to the first evoked EPSC), was significantly decreased in CtBP1944KD neurons, confirming a higher degree of synaptic depression. We also analyzed the depression of neurotransmission during sustained neuronal activity by recording the EPSCs evoked by a train of 50 stimuli at 10 Hz ([Figure 3](#fig3){ref-type="fig"}L). At that frequency, only minor depression of EPSC amplitudes was evident in controls (scr), whereas a pronounced rundown of neurotransmission was measured upon depletion of CtBP1 (CtBP1KD944), which is in line with the high initial Pvr and increased PPR measured in CtBP1KD944 neurons. Thus, depletion of CtBP1 promotes synaptogenesis and elevates Pvr, resulting in increased evoked neurotransmission and contributing to the strongly enhanced short-term depression.

We have previously shown that nuclear CtBP1 acts as a transcriptional corepressor and regulates the expression of plasticity-related genes that might affect synaptogenesis and neurotransmission ([@bib26]). To discriminate between the effects of nuclear and synaptic CtBP1 on synaptic transmission, we expressed CtBP1944KD together with RNAi-resistant variants of CtBP1, which were sorted predominantly to the synapses (EGFP-CtBP1) or only to the nucleus (YFP-CtBP2(NLS)-CtBP1). In EGFP-CtBP1, the N-terminal fusion of EGFP interferes with its nuclear localization, whereas it leaves the synaptic targeting unaffected ([Figure S3](#mmc1){ref-type="supplementary-material"}A) ([@bib26], [@bib61]). The chimeric protein YFP-CtBP2(NLS)-CtBP1, which bears the nuclear localization sequence (NLS) of CtBP2, the paralog of CtBP1 in vertebrates, fused to almost full-length CtBP1, showed restricted nuclear localization ([Figure S3](#mmc1){ref-type="supplementary-material"}A) ([@bib61]). Although expression of synaptic EGFP-CtBP1 on a KD background led to a further increase of EPSC amplitude, expression of nuclear YFP-CtBP2(NLS)-CtBP1 fully rescued the EPSC amplitude ([Figure 3](#fig3){ref-type="fig"}A). These data indicate that the increased size of the evoked response in CtBP1KD944 neurons is a result of the depletion of the nuclear, rather than the synaptic, pool of CtBP1. Similarly, the increased number of morphological synapses as well as Pvr and PPR was substantially normalized upon expression of nuclear YFP-CtBP2(NLS)-CtBP1, indicating that depletion of nuclear CtBP1 leads to increased synaptogenesis and elevated Pvr ([Figures 3](#fig3){ref-type="fig"}G, 3J, and 3K). Expression of YFP-CtBP2(NLS)-CtBP1 also normalized the altered expression of the immediate early gene Arc and brain-derived neurotrophic factor (BDNF) in CtBP1KD944 neurons ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C ), suggesting a link between CtBP1-controlled gene expression and the regulation of synaptic efficacy. We observed an increase in synapse number, Pvr, and PPR upon expression of synaptic EGFP-CtBP1 ([Figures 3](#fig3){ref-type="fig"}G, 3J, and 3K), which further supports the notion that not synaptic but nuclear CtBP1 controls synapse formation and/or maintenance and Pvr. The expression of EGFP-CtBP1 also led to an increase in mEPSC frequency, which might be a consequence of the concomitant strong elevation in synapse number and Pvr ([Figures 3](#fig3){ref-type="fig"}D, 3J, and 3K).

To our surprise, the expression of the nuclear construct YFP-CtBP2(NLS)-CtBP1 in CtBP1KD944 neurons that normalized the evoked neurotransmission and significantly decreased Pvr assessed upon single- or paired-pulse stimulation ([Figures 3](#fig3){ref-type="fig"}A, 3J, and 3K) did not revert the strikingly elevated depression during the train of 50 stimuli at 10 Hz ([Figure 3](#fig3){ref-type="fig"}L). In contrast, expression of synaptic EGFP-CtBP1 in CtBP1KD944, which further enhanced the evoked neurotransmission and left the increased Pvr largely unaffected, increased the steady state response to 10 Hz of stimulation by about 7% (of initial response) compared with CtBP1KD944 ([Figure 3](#fig3){ref-type="fig"}L). This is comparable with data obtained at the calyx of Held, where inhibition of endocytosis decreased the steady-state response by 10% ([@bib19]). Taken together, the complementation experiments revealed that nuclear CtBP1 has an inhibitory effect on basal neurotransmission because of its negative effect on synapse number and SV fusion competency. Interestingly, the nuclear expression of CtBP1 (YFP-CtBP2(NLS)-CtBP1) left the enhanced depression of neurotransmission during repetitive stimulation unaffected, whereas expression of synaptic EGFP-CtBP1 ameliorated the effect of CtBP1 depletion. Because the synaptic rundown during repetitive stimulation is determined not only by the Pvr but also by the size and refill capacity of the total recycling pool of SVs, we next addressed the involvement of synaptic and nuclear CtBP1 in SV retrieval in the following imaging experiments.

Synaptic CtBP1 Is Required for Normal SV Recycling and Short-Term Plasticity of Release {#sec2.4}
---------------------------------------------------------------------------------------

To directly determine the contribution of synaptic and nuclear CtBP1 to the defect in SV retrieval observed in CtBP1KD neurons, we performed imaging experiments in neurons, where CtBP1 KD was complemented by expression of synaptic or nuclear rescue constructs. Synaptically localized EGFP-CtBP1 expressed on CtBP1KD944 background led to an ∼80% restoration of Syt1 Ab uptake driven by network activity. In contrast, the expression of nuclear YFP-CtBP12(NLS)-CtBP1 failed to rescue Syt1 Ab uptake in CtBP1KD944 neurons ([Figures 4](#fig4){ref-type="fig"}A and 4B). In addition, the expression of EGFP-CtBP1 with aspartate-355-to-alanine mutation (D355A), which impairs the fission activities of CtBP1 ([@bib3]), also failed to restore the Syt1 Ab uptake in CtBP1KD neurons ([Figures 4](#fig4){ref-type="fig"}A and 4B), suggesting that the function of CtBP1 in fission is required for normal SV recycling. Next, we tested the ability of synaptic versus nuclear CtBP1 expression to rescue the aberrant exo-endocytosis observed upon depletion of endogenous CtBP1 ([Figures 1](#fig1){ref-type="fig"}H--1K) To that end, we used a sensor composed of synaptophysin fused to the monomeric, orange-pH-sensitive mOrange2 (sypmOr2), which we co-expressed with the EGFP- and YFP-labeled rescue constructs ([Figures 4](#fig4){ref-type="fig"}C and 4D). The fluorescence recovery after stimulation with 200 APs at 20 Hz was significantly retarded in CtBP1KD944: it did not reach full recovery during the time of imaging and had a greater recovery halftime compared with the controls ([Figures 4](#fig4){ref-type="fig"}C and 4D). The expression of synaptic EGFP-CtBP1 on the CtBP1KD944 background fully rescued the normal SV retrieval, whereas nuclear YFP-CtBP2(NLS)-CtBP1 or the fission mutant EGFP-CtBP1D355A failed to do so ([Figures 4](#fig4){ref-type="fig"}C and 4D). Altogether, these data indicate that the synaptic localization and intact fission activities of CtBP1 are crucial for its role in SV retrieval.Figure 4Synaptic CtBP1 Regulates SV Recycling(A) Syt1 Ab uptake was used to evaluate the efficacy of SV recycling in control, CtBP1KD944, and CtBP1KD944 neurons expressing the rescue constructs: EGFP-CtBP1 and YFP-CtBP2(NLS)-CtBP1. Neurons were stained for synapsin to label synapses. Colored images represent overlays. Scale bar: 5 μm.(B) Expression of EGFP-CtBP1 rescues the Syt1 Ab uptake in CtBP1KD944 neurons up to 80% of the control levels. The fission-deficient mutant EGFP-CtBP1D355A has a reduced rescue capacity compared with EGFP-CtBP1. Expression of the nuclear rescue, YFP-CtBP2(NLS)-CtBP1, does not compensate for the decreased Syt1 Ab uptake in CtBP1KD944.(C) Average sypm-Orange2 responses to 200 APs at 20 Hz from control, CtBP1KD944, or CtBP1KD944 neurons expressing EGFP-CtBP1, EGFP-CtBP1D355A, or YFP-CtBP2(NLS)-CtBP1.(D) The endocytic half times, t~1/2~ from the experiment in (C) indicated that the rate of endocytosis was significantly lower in CtBP1KD944 compared with the control. Although expression of EGFP-CtBP1 in CtBP1KD944 cells rescued the endocytosis rate, expression of EGFP-CtBP1D355A or YFP-CtBP2(NLS)-CtBP1 did not.(E) Visualization of short-term depression of exocytosis in CtBP1KD944 and upon expression of rescue constructs. Plotted are average Syt1 Ab-CypHer responses to 40 APs at 20 Hz (a reference response), followed by a 60-s rest period and 200 APs at 10 Hz in the presence of bafilomycin A1. The traces were normalized to the amplitudes of the reference responses in each condition.(F) The absence of synaptic CtBP1 led to a reduction of the plateau fluorescence responses in experiment (E).In the plots the interquartile range and median are depicted as boxes, minimal and maximal values as whiskers and + indicates mean. Data points in curves in [Figures 4](#fig4){ref-type="fig"}C and 4E are depicted as means and SEM In the graphs comparisons with the control are indicated above each box and, comparisons between the conditions are given as horizontal bars. Significance is indicated using asterisks: nsP \> 0.05, ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001, ∗∗∗∗ p \< 0.0001.

To re-evaluate the altered short-term plasticity measured by the electrophysiological recordings of CtBP1-depleted autaptic neurons ([Figure 3](#fig3){ref-type="fig"}L), we monitored the exocytosis of endogenous syt1 during a train of 200 APs at 10 Hz using an antibody against its luminal domain coupled to CypHer5E (Syt1 Ab-CypHer). CypHer5E is a pH-sensitive dye with maximal fluorescence at acidic pH in the vesicle lumen, and fluorescence decline upon SV exocytosis ([@bib20]). Experiments were performed in the presence of bafilomycin A1 ([Figure 4](#fig4){ref-type="fig"}E) or folimycin ([Figure S4](#mmc1){ref-type="supplementary-material"}) to block SV reacidification and to, thus, visualize net SV fusion. To normalize for potential differences in the initial release probability and to, thus, uncover the contribution of SV retrieval, the response amplitudes after a reference train of 40 APs at 20 Hz, which leads to the release of RRP (unchanged between control and CtBP1KD; [Figures 1](#fig1){ref-type="fig"}G, [2](#fig2){ref-type="fig"}I, 2M, [3](#fig3){ref-type="fig"}H, and 3I), were used for normalization, as described previously ([@bib21]). This reference pulse was followed by a brief recovery period and a test stimulus of 200 APs at 10 Hz. The amplitudes of the fluorescence responses to 200 APs were strongly reduced in CtBP1KD944 compared with the control for stimuli delivered at 5, 10, or 40 Hz ([Figures 4](#fig4){ref-type="fig"}E, 4F, [S4](#mmc1){ref-type="supplementary-material"}A, and S4B). The expression of YFP-CtBP2(NLS)-CtBP1 on CtBP1KD944 background did not improve that decrease, whereas the responses in KD neurons expressing EGFP-CtBP1 construct were not significantly different from the control ([Figures 4](#fig4){ref-type="fig"}E and 4F). These experiments further supported the view that synaptic CtBP1 is required for efficient SV recycling during sustained neuronal activity.

Dynamin-Dependent SV Recycling Is Unaffected in CtBP1-Deficient Neurons {#sec2.5}
-----------------------------------------------------------------------

The GTPase dynamin has a key role in the reformation of SVs by catalyzing the fission of SV membranes from the plasma membrane and endosomal structures ([@bib13], [@bib31]). In non-neuronal cells, CtBP1 was described as an accessory protein in the assembly of the dynamin-independent fission machinery, which includes molecules such as ADP ribosylation factor (Arf), phospholipase D (PLD), and lysophosphatidic acid acyltransferase (LPAAT) ([@bib16], [@bib43], [@bib59]). To investigate a possible link between CtBP1 and the established presynaptic endocytic machinery, we assessed the nanoscale localization of CtBP1 with respect to other membranous structures implicated in SV recycling. To that end, we performed super-resolution, dual-color stimulated emission depletion (STED) microscopy of neurons labeled with antibodies against CtBP1, the SV protein Syt1, and several endosome markers, which was followed by co-localization modeling. Dynamin1 labeling was used to visualize the classic endocytic machinery ([Figure 5](#fig5){ref-type="fig"}A). Because many of the components of the CtBP1-associated fission machinery were shown to coordinate the endosomal trafficking of membrane proteins, we also labeled the neurons with markers for early (rab5), late (rab7), and recycling (rab22) endosomes ([Figure 5](#fig5){ref-type="fig"}A). Before staining, neuronal cultures were first silenced with APV ((2*R*)-amino-5-phosphonovaleric acid; (2*R*)-amino-5-phosphonopentanoate) and CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) for 10 min to reduce the intersynaptic variability induced by the endogenous network activity. We analyzed the distance of CtBP1 to other markers at rest and also monitored the co-localization in cells fixed 30 s after stimulation with 200 APs at 40 Hz ([Figure S5](#mmc1){ref-type="supplementary-material"}). Overall, CtBP1 localized in close proximity (0--200 nm) to dynamin1 and Syt1, whereas all endosome markers we probed for were much more distant (100--500 nm) ([Figures 5](#fig5){ref-type="fig"}A, 5B, and [S5](#mmc1){ref-type="supplementary-material"}A--S5E). Synaptic stimulation did not affect the co-localization of CtBP1 with dynamin1 and Syt1 but led to a significant increase in the distance between CtBP1 and endosome markers rab5 and rab7, but not rab22 ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5E). Thus, CtBP1 likely acts at the membrane domain marked by Syt1 and dynamin1, indicating its role in the retrieval of exocytosed SVs. Poor baseline co-localization of CtBP1 with endosomal markers rab5, rab7, and rab22 and subsequent increase of distance upon neuronal stimulation suggest a role for CtBP1 in the formation of vesicular carriers, rather than its constitutive association with intracellular membranous structures.Figure 5CtBP1 and Dynamin Act at the Same Membrane Domain in an Independent, but Likely Cooperative, Manner(A) Orthographic views of the distribution of synaptic CtBP1 and the endocytic markers dynamin1, rab5, rab7, and rab22 in neurons stimulated with 200 APs at 40 Hz. Punctate staining was detected as "spots," and the co-localization was assessed as a distance from the CtBP1-labeled spots (synaptic distance) \<1 μm.(B) The histogram shows the distribution of synaptic puncta co-localizing with CtBP1, binned according to the distance to CtBP1. A significantly smaller distance to CtBP1 is evident for dynamin1 (0--100 and 100--200 nm distance to CtBP1) compared with the other endosome markers.(C) Images of Syt1 Ab-CypHer uptake in control and CtBP1KD944 neurons untreated or treated with dynole 34-2 (C, 30 μM) for 1 h. Live staining for surface GluA receptors was used to mark synapses. Overlays are shown as colored images.(D) Dynole 34-2 inhibits endocytosis in control and CtBP1KD944 neurons. The residual endocytosis is significantly lower upon Dynole 34-2 application in CtBP1944KD, suggesting an interaction of treatments.Scale bars: 0.1 μm in (A); 5 μm in (C).In the plots the interquartile range and median are depicted as boxes, minimal and maximal values as whiskers and + indicates mean. In the graph 5B comparisons are indicated above each group and in 5D comparisons between the conditions are given as horizontal bars. Significance is indicated using asterisks: ∗∗∗∗ p \< 0.0001.

Given that CtBP1 was reported to regulate membrane trafficking in dynamin-independent exocytic and endocytic pathways ([@bib3]), the high synaptic co-localization with dynamin1 was unexpected. Therefore, to test whether CtBP1 contributes to the presynaptic dynamin-dependent endocytosis, we quantified the Syt1 Ab-CypHer uptake in control and CtBP1KD944 neurons treated with the potent dynamin inhibitor dynole 34-2 ([Figures 5](#fig5){ref-type="fig"}C and 5D). Because inhibition of dynamin increases the membrane stranding of SV proteins because of impaired retrieval ([@bib48]), we used Syt1 Ab-CypHer uptake to determine, specifically, the fraction of Syt1 retrieved through dynamin-independent endocytosis. Dynole 34-2 had a comparable effect in control and in CtBP1KD944 neurons and reduced the Syt1 Ab-CypHer uptake by more than 80% ([Figure 5](#fig5){ref-type="fig"}D). The large effect of dynamin inhibition in both conditions confirms the principal requirement of dynamin for efficient SV retrieval at the presynapse. However, because the effects of CtBP1KD and dynole 34-2 were not completely additive, but rather cooperative, and considering the high degree of co-localization observed for CtBP1 and dynamin, we propose that, despite their involvement in independent machineries, they might act in concert at the same membrane domain to mediate effective SV retrieval.

CtBP1 Promotes Retrieval of SVs by Activation of Presynaptic PLD1 {#sec2.6}
-----------------------------------------------------------------

Given the established role of CtBP1 in membrane trafficking in non-neuronal cells, we hypothesized a role of CtBP1-based fission machinery in SV recycling. To test that hypothesis, we first treated control and CtBP1-depleted neurons with brefeldin A (BFA), a fungal antibiotic interfering with intracellular membrane trafficking. BFA targets several proteins involved in membrane trafficking, including CtBP1. It induces ADP-ribosylation of CtBP1 (also known as BFA-ADP-ribosylation substrate \[BARS\]), which interferes with the assembly of CtBP1-based fission complex and results in inhibition of vesicle formation ([@bib6], [@bib55]). We applied BFA (2.5 μM) only 5 min before and during the image acquisition, which we reasoned is too short a time to influence synaptic function by changes in gene expression or soma-to-synapse trafficking. Thus, the effect of BFA treatment more likely reflects an acute inhibition of CtBP1 and the associated fission machinery at the presynapse. In agreement with previous reports ([@bib32], [@bib44]) (but see [@bib29] for lack of effect of BFA on vGLUT-pHluorin), BFA treatment significantly affected the post-stimulus fluorescence decay of sypHy in control neurons ([Figure 6](#fig6){ref-type="fig"}A), indicating that BFA slows down the retrieval of exocytosed SVs. In contrast, the sypHy fluorescence decay was not further affected by BFA in CtBP1KD neurons ([Figure 6](#fig6){ref-type="fig"}B), suggesting that CtBP1-based fission machinery mediates to a great extent the effect of BFA.Figure 6CtBP1 Promotes SV Retrieval by Activation of PLD1(A--D) Average sypHy responses to 200 APs at 20 Hz were recorded, and quantification of t~1/2~ of recovery was performed upon treatment with BFA (A and B) or PLD1 inhibitor (C and D) in control (A and C) or CtBP1KD944 (B and D) neurons. SV retrieval was significantly delayed in BFA-treated neurons (A) but not further affected in BFA treated CtBP1KD944 neurons (B). Treatment with a PLD1 inhibitor affected SV retrieval in control neurons (C) but not in CtBP1KD944 neurons (D). The same controls were plotted in (A) and (C) as well as in (B) and (D), respectively.(E) The endocytic probe mCLING-DY654 was loaded by stimulation of control and CtBP1KD944 neurons with 200 APs at 40 Hz. Synapses were stained with synapsin Ab. Synapses in CtBP1KD944 neurons show a reduction in the mCLING labeling.(F) Quantification of synaptic mCLING IF in (E).(G) Orthographic views of synaptic EGFP-CtBP1 or EGFP-CtBP1S147A (S147A) expressed in CtBP1KD944 neurons and the endocytic probe mCLING-ATTO647N, loaded by stimulation with 200 APs at 40 Hz.(H) Quantification of the mCLING intensities from EGFP-CtBP1- and S147A-labeled synapses in (G).(I) Correlation of mCLING intensities and the distances to EGFP-CtBP1. The intensity of the endocytic probe was inversely correlated with the distance to EGFP-CtBP1.(J) The histogram shows the distribution of mCLING puncta co-localizing with EGFP-CtBP1 or S147A, binned according to the distance mCLING-CtBP1. Note the shift in the histogram of EGFP-CtBP1 toward closer distances.Scale bars: 2 μm in (E); 0.1 μm in (G).In the plots the interquartile range and median are depicted as boxes, minimal and maximal values as whiskers and + indicates mean. Data points in curves in [Figures 6](#fig6){ref-type="fig"}A--6D are depicted as means and SEM. Significance is indicated using asterisks: nsP \> 0.05, ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗∗ p \< 0.0001.

The precise molecular mechanism of CtBP1-mediated membrane fission is still not fully understood. It was suggested that CtBP1-based fission complex drives membrane budding and fission by catalyzing the remodeling of membrane lipids, which leads to formation of fission-prone membrane domains. In non-neuronal cells, CtBP1 was shown to interact and activate the phosphodiesterase activity of phospholipase D1 (PLD1), an enzyme catalyzing the conversion of phosphatidylcholine (PC) into the fusogenic phosphatidic acid (PA) ([@bib9], [@bib16], [@bib47]). Although PLD1 was shown to have a role in the control of neurotransmitter release in *Aplysia* ([@bib23]) and in the secretion of neuropeptides in chromaffin cells ([@bib65]), its function in the regulation of SV recycling in mammalian synapses has not been investigated yet. Therefore, next, we tested the involvement of PLD1 in SV recycling and its link to CtBP1-dependent SV retrieval. Acute application of VU 0155069 (1 μM for 5 min), a specific inhibitor of PLD1, led to a 2-fold decrease in the rate of sypHy retrieval in control neurons, whereas it had no effect on the endocytosis rate in CtBP1KD neurons ([Figures 6](#fig6){ref-type="fig"}C and 6D).

Considering the activity-induced recruitment of CtBP1 to nanodomains co-labeled with dynamin1 and Syt1 and its dissociation from the endosome markers rab5 and rab7, we hypothesized that CtBP1 localizes to the membrane regions, in which endocytosis of newly released SV proteins takes place. To test whether this is indeed the case, we performed imaging with fluorescently labeled mCLING: a lipophilic reacidification-independent probe suitable for STED nanoscopy of endocytic organelles ([@bib51]). We loaded mCLING into the synapses of APV and CNQX silenced (for 10 min) controls and CtBP1KD944 neurons by stimulation with 200 APs at 40 Hz and fixed them 30 s later. The mCLING labeling was notably reduced in the synapses in CtBP1KD944 neurons in comparison to the control ([Figures 6](#fig6){ref-type="fig"}E and 6F) but was again evident upon the expression of the shRNA-resistant EGFP-CtBP1 construct on a CtBP1KD944 background ([Figure 6](#fig6){ref-type="fig"}G). We next performed dual-color STED nanoscopy, followed by co-localization modeling, to assess the co-distribution of mCLING and EGFP-CtBP1 ([Figure 6](#fig6){ref-type="fig"}G). This analysis revealed a significant negative correlation between the intensity of mCLING and the distance to individual EGFP-CtBP1 puncta, which supports a role of CtBP1 in SV endocytosis ([Figure 6](#fig6){ref-type="fig"}I).

Phosphorylation of CtBP1 at serine 147 (S147), mediated by the kinase Pak1, was found to strongly increase the capacity of CtBP1 to stimulate membrane fission by increasing its ability to activate PLD1 ([@bib16], [@bib39]). To test the importance of this regulation at the presynapse we compared the mCLING labeling in neurons expressing the RNAi resistant EGFP-CtBP1 or EGFP-CtBP1S147A construct on CtBP1KD944 background. The mCLING labeling was reduced by 80% in cells expressing EGFP-CtBP1S147A as compared to cells expressing EGFP-CtBP1 ([Figures 6](#fig6){ref-type="fig"}G and 6H) indicating a lower ability of this mutant to rescue stimulus-induced membrane retrieval upon CtBP1KD. Moreover, the co-distribution between mCLING and S147A mutant was shifted toward higher distances compared to EGFP-CtBP1 ([Figure 6](#fig6){ref-type="fig"}J), which likely reflects impaired recruitment to the sites of endocytosis. Taken together, these data indicate that the presence of CtBP1 at the endocytic sites and its phosphorylation at S147 are key factors determining the efficacy of SV retrieval.

Phosphorylation of CtBP1 Regulates Its Distribution between the CAZ and the Presynaptic Endocytic Sites {#sec2.7}
-------------------------------------------------------------------------------------------------------

CtBP1 is recruited to the synapse via a direct interaction with the presynaptic scaffolding proteins Bsn and Pclo ([@bib26], [@bib57]). Despite the tight functional coupling between SV fusion and endocytosis, it is well established that the two processes take place at distinct membrane domains within the presynapse ([@bib17], [@bib40]). Thus, the association of CtBP1 with Bsn and Pclo, which are established components of the SV release sites, is seemingly in disagreement with the proposed function of CtBP1 in SV endocytosis. To address that apparent ambiguity, we performed the following series of experiments. First, we performed co-immunoprecipitation (coIP) of Bsn with EGFP-CtBP1, overexpressed in primary cortical cultures in a basal state or upon a treatment with the Pak1 inhibitor IPA3 for 1 h ([Figure 7](#fig7){ref-type="fig"}A). In a basal state, a considerable coIP of CtBP1 with PLD1, but only a low binding to Bsn, was detected. The IPA3 treatment visibly reduced the overall serine/threonine phosphorylation of CtBP1 ([Figures 7](#fig7){ref-type="fig"}C and 7D). Consistent with the requirement for Pak1-dependent phosphorylation of CtBP1 for its association with PLD1, IPA3 reduced the coIP of PLD1 with CtBP1 to an undetectable minimum but increased the association of CtBP1 with Bsn ([Figures 7](#fig7){ref-type="fig"}A and 7B). This indicates that the phosphorylation of CtBP1 by Pak1 acts as a molecular switch, which triggers its dissociation from Bsn and binding to PLD1. To further test that hypothesis, we compared the nanoscale co-localization of EGFP-CtBP1 or S147A mutant with endogenous Bsn at synapses of acutely silenced neurons before and upon stimulation with 200 APs at 40 Hz. Consistent with our previously published observations, stimulation led to a tighter co-localization of EGFP-CtBP1 and Bsn ([Figures 7](#fig7){ref-type="fig"}E and 7F) ([@bib26]). EGFP-CtBP1S147A showed a greater co-localization with Bsn than EGFP-CtBP1 in silenced cells, and no effect on its co-distribution with Bsn was observed upon stimulation ([Figures 7](#fig7){ref-type="fig"}E and 7F). This supports our view that Pak1-mediated phosphorylation of S147 favors a redistribution of CtBP1 from Bsn toward PLD1, thus, promoting SV retrieval through activation of PLD1.Figure 7PAK1 Phosphorylation Mediates a Switch in the Association of CtBP1 with Bsn and PLD1(A and B) Inhibition of Pak1 increases the binding of EGFP-CtBP1 to Bsn and reduces its binding to PLD1. (A) Co-IP with EGFP antibodies was performed from neuronal cultures expressing EGFP-CtBP1 and treated or not with the Pak1 inhibitor IPA3 (50 μM, 1 h). (B) Quantification of the binding of Bsn to CtBP1.(C and D) IP with EGFP antibodies was performed from whole cell lysates or P2 fractions of neuronal cultures expressing EGFP-CtBP1 and treated or not with the Pak1 inhibitor IPA3 (50 μM for 1 h). (C) The western blots were probed with a pan anti Ser/Thr Ab to visualize the phospho-Ser/Thr levels of CtBP1. (D) Quantification of the Ser/Thr phosphorylation of CtBP1 is shown.(E) The two-color STED images show a tighter co-localization of EGFP-CtBP1 with Bsn after stimulation with 200 APs at 40 Hz compared with cells at rest. EGFP-CtBP1S147A displays a tight co-localization with Bsn independently of neuronal activity.(F) The histogram shows the relative distribution of Bsn puncta co-localizing with EGFP-CtBP1 or S147A at rest and upon stimulation.Scale bar: 40 nm. In the plots the interquartile range and median are depicted as boxes, minimal and maximal values as whiskers, and + indicates mean. Significance is indicated by asterisks: ^∗∗^p \< 0.01 and ^∗∗∗∗^ p \< 0.0001.

Discussion {#sec3}
==========

Nuclear CtBP1 Restricts Synaptogenesis, whereas Synaptic CtBP1 Promotes SV Retrieval {#sec3.1}
------------------------------------------------------------------------------------

In this study, we investigated the effect of CtBP1 depletion on synaptic function using KD and KO approaches. Neurons lacking CtBP1 had a normal overall morphology but showed a significant shift in the distribution of SVs toward the AZs and enlargement of the docked SVs at rest. Interestingly, a similar change in the distribution of SVs was also observed after treatment with BFA ([@bib49]), which, as shown here, inhibits SV recycling via CtBP1 and upon depletion of Arf6, a component of the CtBP1-dependent fission machinery and an alternative activator of PLD1 ([@bib16], [@bib56], [@bib59]). Thus, it is tempting to speculate that insufficient PLD1 activity in the absence of CtBP1 might cause this phenotype. The efficiency of fission during vesicle budding crucially affects the size of the resulting vesicular structures. In line with that, enlarged SVs were observed in mutants of dynamin, AP180, and syndapin, which have been implicated in different steps of SV reformation, like fission, recruitment of the clathrin-coat, or induction/sensing of membrane curvature ([@bib12], [@bib30], [@bib66]). Thus, an involvement of CtBP1 in the fission of the SV membranes, might explain the changes in SV size observed in *Ctbp1* KO synapses.

Interference with CtBP1 expression in cultured neurons revealed its multifaceted role in the regulation of synaptogenesis and neurotransmission. A rescue strategy with CtBP1 fusion proteins selectively sorted to nucleus or synapses revealed distinct roles for CtBP1 in these spatially separated neuronal compartments. Nuclear CtBP1 restricted synaptogenesis and presynaptic vesicular release probability, possibly by repressing the expression of plasticity-related genes, such as neurotrophins or neurotransmitter receptors ([@bib26]). In line with that, the expression of the nuclear rescue construct YFP-CtBP2(NLS)-CtBP1 could normalize the higher number of morphologically identified excitatory synapses, the enlarged amplitudes of the evoked EPSCs, and the higher Pvr and PPR observed in CtBP1KD944 neurons. Notably, the expression of the synaptic rescue (EGFP-CtBP1) on the CtBP1KD944 background tended to enhance the effect of CtBP1 depletion on synapse density and EPSC amplitude, suggesting a dominant-negative effect of this construct on the nuclear functions of CtBP1. One possible explanation of this effect is that the EGFP-CtBP1 binds to the nuclear CtBP1-interacting partners and promotes their cytoplasmic retention. However, expression of this construct on a CtBP1KD944 background compensated for the defects in SV retrieval and ameliorated the enhanced short-term depression of neurotransmission upon repetitive stimulations. This indicates a positive effect of synaptic CtBP1 on neurotransmission. Based on that, we can speculate that the recently reported activity-induced redistribution of CtBP1 from nucleus to presynapses exerts a dual-positive effect on neurotransmission ([@bib26]). Thus, during bursts of intense neuronal activity the reduced nuclear abundance of CtBP1 will lead to a release of the transcriptional block of neuroplasticity-related genes, whereas the enhanced synaptic targeting will facilitate SV recycling.

CtBP1-Mediated Membrane Fission and PLD1 Activation Are Required for SV Retrieval {#sec3.2}
---------------------------------------------------------------------------------

Our data indicate that CtBP1-mediated membrane fission and activation of PLD1 have an important contribution to the effective SV retrieval at the presynapse. We provide the following evidence supporting that view: (1) the CtBP1D355A fission-deficient mutant failed to rescue SV retrieval in CtBP1KD944, (2) the CtBP1S147A mutant that could not recruit PI4KIIIβ/ARF6 and activate PLD1 failed to rescue endocytosis visualized with mCLING, and (3) the pharmacological inhibition of CtBP1-based fission complex, using BFA or inhibition of PLD1 activity, phenocopied the aberrant SV retrieval observed in CtBP1KD. Our data also indicate a role for PLD1 in SV recycling at hippocampal synapses. PLD1 was detected in synaptic plasma membranes isolated from rat synaptosomes, and interference with PLD1 was shown to affect acetylcholine release from nerve ganglia in *Aplysia* ([@bib23]). However, PLD1 was mainly discussed in the context of exocytosis in neurons and chromaffin cells ([@bib65]). Our data indicate a role for PLD1 in SV retrieval in hippocampal synapses and reveal a requirement for CtBP1-mediated activation of PLD1 in that process. The activation of PLD1 depends on Pak1-mediated phosphorylation of CtBP1. It is unclear whether and how Pak1 activity is regulated at the presynapse, but based on our findings, we can speculate that the level of presynaptic Pak1 activity could regulate the SV retrieval and thereby modulate short-term plasticity of neurotransmission. Interestingly, the phosphorylation of S147 of CtBP1 by Pak1, which is necessary for PLD1 activation, also induces dissociation of CtBP1 from Bsn, which anchors it to the active zones. This suggests that Pak1 activity might induce rapid activation of PLD1 near presynaptic release sites and thereby link SV fusion and retrieval in time, space, and extent.

CtBP1-Mediated Lipid Reorganization in SV Retrieval {#sec3.3}
---------------------------------------------------

CtBP1-based fission machinery was proposed to act in a dynamin-independent manner at the Golgi and plasma membrane in non-neuronal cells ([@bib3], [@bib16], [@bib64]). However, the fluid-phase endocytosis switched from a CtBP1-dependent to a dynamin-dependent mechanism in fibroblasts in which CtBP1 was knocked out ([@bib3]), suggesting a tight interaction between those pathways. Thus, it is possible that CtBP1- and dynamin-based fission machineries converge in their action at the presynapse, where particularly potent endocytosis is required for sustained SV replenishment. CtBP1 was suggested to mediate fission of target membranes by activation of lipid enzymes, such as PLD1 and LPAAT, which generate curvature-inducing lipid modifications ([@bib16], [@bib39], [@bib43]), and by their recruitment to the machinery, initiate vesicular budding and tubulation ([@bib59]). PLD1 and LPAAT catalyze the production of the fusogenic PA, which, because of its conical shape, promotes the negative membrane curvature necessary for vesicle fusion and fission ([@bib33]). In addition to its structural role, PA was also linked to the generation of PI(4,5)P~2~, the phospholipid involved in the recruitment of numerous proteins involved in endocytosis, including dynamin ([@bib45]). Specifically, PA activates PI kinases necessary for PI(4,5)P~2~ production ([@bib28], [@bib42]), and intriguingly, one of them, PI4KIIIβ, is a component of the CtBP1-based fission complex in non-neuronal cells ([@bib59]). Thus, it is likely that CtBP1 promotes SV retrieval by recruitment and activation of multiple lipid-modifying enzymes, which drive the formation of a lipid-environment permissive for compensatory endocytosis. The tight co-localization of CtBP1 and dynamin and the cooperative effect of the interference with their functions on SV recycling support that view. However, future studies will be needed to gain more insight into the mechanisms linking and regulating the different fission machineries involved in SV recycling.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse anti-CtBP1BD BiosciencesCat\#612042; RRID:[AB_399429](nif-antibody:AB_399429){#intref0010}Mouse anti-CtBP2BD BiosciencesCat\#612044; RRID:[AB_399431](nif-antibody:AB_399431){#intref0015}Mouse anti-synaptotagmin1 lumenal domain Oyster550Synaptic SystemsCat\#105311; RRID:[AB_993036](nif-antibody:AB_993036){#intref0020}Mouse anti-synaptotagmin1 lumenal domain CypHer5E-labeledSynaptic SystemsCat\#105311CpH; RRID:[AB_2199307](nif-antibody:AB_2199307){#intref0025}Mouse anti-rab5Synaptic SystemsCat\#108011; RRID:[AB_887773](nif-antibody:AB_887773){#intref0030}Mouse anti-rab7AbcamCat\#ab50533; RRID:[AB_882241](nif-antibody:AB_882241){#intref0035}Mouse anti-phosphoserine/threonineBD BiosciencesCat\#612548; RRID:[AB_399843](nif-antibody:AB_399843){#intref0040}Mouse anti-GluA Oyster 550-labeledSynaptic SystemsCat\#182411C3; RRID:[AB_2619877](nif-antibody:AB_2619877){#intref0045}Mouse anti-α-tubulinSigma AldrichCat\# T9026; RRID:N/ARabbit anti-CtBP1Synaptic SystemsCat\#222002; RRID:[AB_2086638](nif-antibody:AB_2086638){#intref0050}Rabbit anti-GFPAbcamCat\#ab6556; RRID:[AB_305564](nif-antibody:AB_305564){#intref0055}Rabbit anti-SV2BSynaptic SystemsCat\#119103; RRID:[AB_2725759](nif-antibody:AB_2725759){#intref0060}Rabbit anti-GAPDHAbcamCat\#ab37168; RRID:[AB_732652](nif-antibody:AB_732652){#intref0065}Rabbit anti-synaptotagmin1 lumenal domain Oyster 550-labeledSynaptic SystemsCat\#105103C3; RRID:[AB_887829](nif-antibody:AB_887829){#intref0070}Rabbit anti-synaptotagmin 1 lumenal domainSynaptic SystemsCat\#105102; RRID:[AB_887835](nif-antibody:AB_887835){#intref0075}Rabbit anti-dynamin1AbcamCat\#ab3456; RRID:[AB_303818](nif-antibody:AB_303818){#intref0080}Rabbit anti-rab22aAbcamCat\#ab137093; RRID:N/ARabbit anti-Phospholipase D1Cell Signaling technologiesCat\#3832S; RRID:[AB_2172256](nif-antibody:AB_2172256){#intref0085}Rabbit anti-Homer1Synaptic SystemsCat\#160003; RRID:[AB_887730](nif-antibody:AB_887730){#intref0090}Guinea pig anti-synapsin 1, 2Synaptic SystemsCat\#106004; RRID:[AB_1106784](nif-antibody:AB_1106784){#intref0095}Guinea pig anti-synaptophysin 1Synaptic SystemsCat\#101004; RRID:[AB_1210382](nif-antibody:AB_1210382){#intref0100}Guinea pig anti-Piccolo[@bib8]N/AAlexa Fluor 488 donkey anti-mouse secondary antibodyThermoFisher ScientificCat\#A21202; RRID:[AB_141607](nif-antibody:AB_141607){#intref0105}Alexa Fluor 488 donkey anti-rabbit secondary antibodyThermoFisher ScientificCat\#A21206; RRID:[AB_141708](nif-antibody:AB_141708){#intref0110}Alexa Fluor 488 donkey anti-guinea pig secondary antibodyDianova/Jackson ImmunoResearch LabsCat\#706-545-148; RRID:[AB_2340472](nif-antibody:AB_2340472){#intref0115}Cy3 donkey anti-mouse secondary antibodyDianova/Jackson ImmunoResearch LabsCat\#715-165-150; RRID:[AB_2340813](nif-antibody:AB_2340813){#intref0120}Cy3 donkey anti-rabbit secondary antibodyDianova/Jackson ImmunoResearch LabsCat\#711-165-152; RRID:[AB_2307443](nif-antibody:AB_2307443){#intref0125}Cy3 donkey anti-guinea pig secondary antibodyDianova/Jackson ImmunoResearch LabsCat\#706165-148; RRID:[AB_2340460](nif-antibody:AB_2340460){#intref0130}647 donkey anti-mouse secondary antibodyThermoFisher ScientificCat\#A31571; RRID:[AB_162542](nif-antibody:AB_162542){#intref0135}Cy5 donkey anti-rabbit secondary antibodyDianova/Jackson ImmunoResearch LabsCat\#711-175-152; RRID:[AB_2340607](nif-antibody:AB_2340607){#intref0140}Cy5 donkey anti-guinea pig secondary antibodyDianova/Jackson ImmunoResearch LabsCat\#706-175-148; RRID:[AB_2340462](nif-antibody:AB_2340462){#intref0145}IRDye® 680 Donkey Anti-Mouse secondary antibodyLI-CORCat\#926-68072; RRID:[AB_10953628](nif-antibody:AB_10953628){#interref225}IRDye 680RD Goat anti-Rabbit secondary antibodyLI-CORCat\#926-68071; RRID:[AB_10956166](nif-antibody:AB_10956166){#intref0150}IRDye 800CW Donkey anti-guinea pig secondary antibodyLI-CORCat\#926-32411; RRID:[AB_1850024](nif-antibody:AB_1850024){#intref0155}Atto 647N- goat anti mouse secondary antibodyRocklandCat\#610-156-121; RRID:[AB_10894200](nif-antibody:AB_10894200){#intref0160}Atto 647N- goat anti rabbit secondary antibodyRocklandCat\#611-156-122; RRID:[AB_10893043](nif-antibody:AB_10893043){#intref0165}Abberior STAR 580- anti mouse secondary antibodyAbberior GmbHCat\#2-0002-005-1; RRID:[AB_2620153](nif-antibody:AB_2620153){#intref0170}Abberior STAR 580- anti rabbit secondary antibodyAbberior GmbHCat\#2-0012-005-8; RRID:[AB_2810981](nif-antibody:AB_2810981){#intref0175}**Chemicals, Peptides, and Recombinant Proteins**APVTocris0106 CAS: 79055-68-8CNQXTocris1045 CAS: 479347-85-8bafilomycin A1Merck/Millipore196000 CAS: 88899-55-2concanamycin ATocris2656 CAS: 80890-47-7brefeldin ATocris1231 CAS: 20350-15-6VU 0155069Tocris3575 CAS: 1781834-89-6Dynole 34-2Abcamab120463 CAS: 1128165-88-7IPA 3Tocris3622 CAS: 42521-82-4cOmplete ULTRA TabletsRoche/Merck05892791001PhosSTOPRoche/MerckPHOSS-ROmCLING-ATTO647NSynaptic Systems710 006AT1mCLING-DY654Synaptic Systems710 006DY1**Critical Commercial Assays**RT^2^ Profiler PCR Array Rat Synaptic PlasticityQIAGENPARN-126ZRNeasy Plus Mini KitQIAGEN74134μMACS GFP Isolation KitMiltenyi Biotec130-091-125μ ColumnsMiltenyi Biotec130-042-701**Deposited Data**Raw and analyzed dataThis paperN/A**Experimental Models: Cell Lines**HEK293T (human, embryonic kidney)ATCCCRL-3216**Experimental Models: Organisms/Strains**Rat: WistarCharles RiverWistar IGS RatRat: Sprague-DawleyCharles RiverCD® (Sprague Dawley) IGS RatMouse: C57BL/6NCharles RiverC57BL/6NCrlMouse: *Ctbp1*^tm1Sor^ (*Ctbp1* KO)Jackson Lab(Stock No: 011054)**Oligonucleotides**CtBP1KD944 shRNA target sequence: GCTTCAACGTCC\
TCTTCTA[@bib26]N/ACtBP1KD467 shRNA target sequence: GCACAGTGGAGA\
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Lead Contact And Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents can be directed to and will be fulfilled by the Lead Contact, Anna Fejtova (<Anna.Fejtova@uk-erlangen.de>). Plasmids generated in this study are available from the lead contact upon request and their distribution is regulated by an institutional MTA.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Animals {#sec4.3.1}

Cells and tissues used in this study were obtained from Wistar rats, Sprague-Dawley rats, C57BL/6N mice and *Ctbp1*^tm1Sor^ (*Ctbp1* KO) mouse strain ([@bib18]) backcrossed to C57BL/6N. Animals of both sexes were used. Animal handling was performed according to the regulations of the European Committees Council Directive 86/609/EEC, Landesverwaltungsamt Sachsen-Anhalt, (AZ: T LIN-AF/2009), Berlin state government agency for Health and Social Services and the animal welfare committee of Charité Medical University Berlin, Germany (license no. T 0220/09).

### Lentiviral particle production {#sec4.3.2}

Lentiviral particles were produced as described previously with slight modifications ([@bib26]). HEK293T cells (ATCC CRL-3216) were grown in media containing 10% fetal bovine serum (FBS) to 80% confluence and transfected using the calcium phosphate method ([@bib11]) with three vectors: FUGW-based transfer, psPAX2 packaging, and p-CMV-VSV-G pseudotyping vectors (ratio 2:1:1). Cells were incubated for 8 h at 37°C in 5% CO~2~ atmosphere, before the FBS medium was replaced by Neurobasal (NB) medium, containing B27, antibiotics, and 0.8 mM glutamine. Virus-containing media was collected at day 3 and 4, passed through 0.45 μm filter and used either directly for transducing primary neurons or stored at −80°C.

### Primary cultures and treatments {#sec4.3.3}

Primary dissociated hippocampal and cortical cultures from rat embryos and C57BL/6N and *CtBP1* KO neonatal mice were prepared as described in [@bib26] and [@bib36].

Autaptic cultures from P0-P2 C57BL/6N mice were grown on coverslips with a dotted pattern of astrocytic microislands ([@bib2]). To grow neurons individually, 0.15% agarose solution was spread on 30 mm coverslips. Coating solution containing collagen and poly-D-lysine in acetic acid was stamped onto the agarose, thus creating small islands of substrate with a diameter of about 100 μm. Hippocampi were dissected out and digested with 25 U/ml of papain for 60 min at 37°C. After papain inactivation, hippocampi were mechanically dissociated in Neurobasal-A medium containing B-27, Glutamax and penicillin/streptomycin. To obtain a desirable distribution of neurons, astrocytes and neurons were plated onto the coverslips with a density of 50000 and 3000 cells/coverslip, respectively. To knock down CtBP1, neurons were infected 24 hours later with lentiviruses expressing scrambled, shRNA against CtBP1 or the rescue constructs EGFP-CtBP1 and YFP-CtBP2(NLS)-CtBP1. Experiments were performed on DIV14 (electrophysiological recordings) or DIV16-21 (fixed and live-cell imaging).

Hippocampal neurons were co-transfected with syp mOrange2 and a plasmid expressing CtBP1 scr, CtBP1KD944 or CtBP1KD944 along with shRNA-resistant EGFP-CtBP1, EGFP-CtBP1D355A or YFP-CtBP2(NLS)-CtBP1 at DIV6 using Lipofectamine 2000 (Thermo Fisher Scientific) as recommended by the manufacturer. The neurons were used for live imaging 8 to 10 days after the transfection.

For the treatments, the following drugs were used: d-(-)-2‐amino-5-phosphonopentanoic acid (APV, 50 μM; Tocris), 6-cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, 10 μM; Tocris), bafilomycin A1 (1 μM, Merck/Millipore), folimycin/concanamycin A (80nM, Tocris), brefeldin A (2.5 μM, Tocris), VU 0155069 (PLD1 inhibitor, 1 μM, Tocris). Neurons were pre-treated with these inhibitors for 5 minutes before imaging and the inhibitors were kept in the imaging buffer during the whole imaging assay. IPA 3 (50 μM, Tocris) was applied for 1h before the cells were collected or lysed for western blotting. The inhibitors of dynamin, Dynole 34-2 (30 μM, Abcam) was applied for 1h during Syt1 Ab-CypHer uptake. The fixable endocytosis marker mCLING (ATTO647N-labeled in [Figures 6](#fig6){ref-type="fig"}G and 6H and DY654-labeled in [Figures 6](#fig6){ref-type="fig"}E and 6F; 1:100, Synaptic Systems) was applied to neurons in extracellular solution containing 50 μM APV and 10 μM CNQX, for 2 min before cells were stimulated with 200 AP at 40 Hz. To eliminate unspecific labeling neurons were washed three times with extracellular solution and fixed within 30 s after stimulation with a mixture of 4% paraformaldehyde (PFA) and 0.2% glutaraldehyde, as recommended by the manufacturer.

Method Details {#sec4.4}
--------------

### Antibodies {#sec4.4.1}

The following primary antibodies were used in this study: **Mouse antibodies against**: CtBP1 (immunocytochemistry (ICC) 1:1,000, western blotting (WB) 1:5,000, BD Biosciences, 612042), CtBP2 (WB 1:2000 BD Biosciences, 612044) synaptotagmin1 lumenal domain Oyster 550 or CypHer5E-labeled (ICC 1:200, Synaptic Systems, 105311 and 105311CpH), rab5 (ICC 1:500, Synaptic Systems, cells stained with this antibody were fixed with ice-cold methanol for 10 min, followed by rehydration in PBS for 20 min, 108011), rab7 (ICC 1:1,000, Abcam, ab50533), phosphoserine/threonine (WB 1:1000, BD Biosciences, 612548), GluA Oyster 550-labeled (ICC 1:200, Synaptic Systems, 182411 C3), α-tubulin (WB 1:1000, Sigma Aldrich); **Rabbit antibodies against**: CtBP1 (ICC 1:1,000, WB 1:1,000, Synaptic Systems, 222002), GFP (ICC 1:1,000, WB 1:5,000, Abcam, ab 6556), SV2B (ICC 1:200, Synaptic Systems, 119103), GAPDH (WB 1:3000, Abcam, ab37168), synaptotagmin1 lumenal domain Oyster 550-labeled (ICC 1:200, Synaptic Systems, 105103C3), synaptotagmin 1 lumenal domain (WB 1:1000, Synaptic Systems, 105102), dynamin1 (ICC 1:1000, Abcam, ab3456), rab22a (ICC 1:1000, Abcam, ab137093), Phospholipase D (WB 1:1000, Cell Signaling technologies, 3832S), Homer1 (ICC 1:500, Synaptic Systems, 160003); **Guinea pig antibodies against**: synapsin 1, 2 (ICC 1:1,000, Synaptic Systems, 106004), synaptophysin 1 (ICC 1:1,000, Synaptic Systems, 101004), Piccolo (WB 1:2000, [@bib8]).

The following secondary cross-adsorbed antibodies were used in this study: Alexa 488- (ICC: 1:1,000), Cy3-(ICC: 1:1,000), Cy5-(ICC: 1:2,000), Alexa 680- (WB 1:20,000) conjugated whole IgGs against mouse, rabbit and guinea pig were obtained from Invitrogen/Mol. Probes, IRDye 800CW (WB 1:20,000) and Atto 647N (1:500, 610-156-121 and 611-156-122) from Rockland and Abberior STAR 580 (1:100, 2-0002-005-1 and 2-0012-005-8) from Abberior GmbH.

### DNA constructs {#sec4.4.2}

EGFP-tagged CtBP1 was generated by cloning the sequence for CtBP1-S into pEGFPC vector. Subsequently, the DNA cassette containing EGFP-CtBP1 was shuttled into FUGW H1 lentiviral vector ([@bib38]), replacing EGFP coding sequence. The shRNAs against CtBP1 and YFP-CtBP2(NLS)-CtBP1 constructs were reported previously ([@bib26], [@bib61]). All point mutations, including the silent point mutations for the rescue experiments, were introduced by inverse PCR using primers containing the mutations and CtBP1-S coding sequence cloned in pBluescriptII SK-(AgilentTechnologies). The ratio:sypHy construct and syp mOrange2 used in this study were reported in [@bib37], [@bib52], and [@bib10], respectively. All constructs were verified by sequencing.

### Ultrastructural analysis {#sec4.4.3}

Organotypic hippocampal slice cultures from *Ctbp1* KO and WT littermates were prepared at postnatal day 0 and were cryo-fixed after 4-5 weeks *in vitro* under cryo-protectant conditions (20% bovine serum albumin in culture medium) using the High Pressure Freezing device HPM100 (Leica), and cryo-substituted in Freeze Substitution Processor EM AFS2 (Leica) according to previously published protocols ([@bib24], [@bib25]). For 2D analyses of synaptic morphology, electron micrographs were acquired from 60 nm-thick plastic sections with a transmission electron microscope (Zeiss LEO 912-Omega) operating at 80 kV. For 3D electron tomographic analysis of docked SV, 200 nm-thick plastic sections were imaged in a JEM-2100 transmission electron microscope (JEOL) operating at 200 kV. SerialEM ([@bib41]) was used to acquire single-axis tilt series (−60°/-55° to ± 55°/ ± 60°; 1° increments) at 25,000 fold magnification with an Orius SC1000 camera (Gatan, Inc.). Tomograms reconstructed from tilt series using the IMOD package ([@bib35]) had a voxel size of x,y,z = 1.82 nm. Tomogram acquisition and analyses were performed blindly. Quantifications were done manually using ImageJ (National Institutes of Health). The smallest SV distances from the outer leaflet of the SV membrane to the inner leaflet of the AZ plasma membrane were measured using the straight line tool of the ImageJ software. Only SVs observed to be in physical contact at their midline with the presynaptic membrane were considered docked (0-2 nm distance). The mean SV diameter was calculated from the area of the SV measured at its midline to the outer leaflet of the SV membrane using the elliptical selection tool of ImageJ.

For illustrative purposes, images depicting tomographic sub-volumes represent an overlay of seven consecutive tomographic slices produced using the slicer tool of the 3dmod software of the IMOD software package to generate an approximately 13 nm thick sub-volume.

### Quantitative real-time PCR {#sec4.4.4}

Quantitative real-time PCR was performed as described in [@bib26]. Total RNA was extracted from primary cortical cultures (DIV16) superinfected on the day of plating with lentiviral particles driving the expression of scrambled, shRNA944 and YFP-CtBP2(NLS)-CtBP1, using RNeasy Plus Mini Kit (QIAGEN) and following the instructions of the manufacturer. The transcript levels of BDNF and Arc were analyzed by a customized version of Rat Synaptic Plasticity RT^2^ Profiler PCR Array (QIAGEN). To calculate the expression of BDNF and Arc in relation to a reference gene we used ΔΔCP method. We used the 'second derivative maximum analysis' method, available in the software of Roche LightCycler480, to determine the crossing point (CP) of the PCR. The expression of lactate dehydrogenase A was used as a reference to calculate the relative mRNA levels of BDNF and Arc.

### Biochemical experimental work {#sec4.4.5}

Cortical neurons with cell density 10 million per 75‐cm2 flask were superinfected with lentiviral particles, driving the expression of EGFP-CtBP1. Cells (DIV16) were lysed in 10mM Tris--HCl, 150mM NaCl, 2% SDS, 1% deoxycholate and 1% Triton X-100 containing complete protease inhibitors (Roche), and PhosStop (Roche) and co-immunoprecipitations were performed using MicroMACS anti‐GFP MicroBeads and MicroColumns (Miltenyi Biotec) according to the instructions from the manufacturer.

Crude synaptosomal fraction (P2) was prepared as follows: First, cell or mouse brain homogenates were prepared in HEPES-buffered sucrose (4 mM HEPES pH 7.4, 0.32 M sucrose) and centrifuged at 1000 x g for 10 min to pellet the nuclear fraction (P1). The supernatant was then centrifuged at 12000 g for 20 min to give the crude synaptosomal pellet (P2). The crude synaptosomal fraction (P2) was lysed in 10 mM Tris--HCl, 150mM NaCl, 2% SDS, 1% deoxycholate and 1% Triton X-100 containing complete protease inhibitors (Roche), and PhosStop (Roche) and further subjected to IP or western blotting.

Protein samples were separated on 5%--20% Tris-glycine gels, or 3.5%--8% Tris-acetate gels as described previously ([@bib26]) or on 10% (Bio-Rad TGX-Stain free gels) and blotted onto Millipore Immobilon FL PVDF membranes by tank or semidry blotting. Immunodetection was performed on Odyssey Infrared Scanner (LI-COR). For the quantification of the immunoblots the integrated density (ID) of signals was measured using ImageJ by setting rectangular ROIs with identical size around or using Image Studio Software (LI-COR). Samples of each experimental group were always loaded and quantified on the same membrane. TCE total protein stain was used for normalization in [Figure 1](#fig1){ref-type="fig"}B. In [Figure S2](#mmc1){ref-type="supplementary-material"}A, GAPDH or α-tubulin were used for normalization in homogenates and P2 fraction, respectively. The values for ID of CtBP1 ([Figures 7](#fig7){ref-type="fig"}A--7D) were normalized to the corresponding expression levels of the two proteins in each experimental group. The antibodies used for immunodetection and the molecular weight of the markers are indicated in the figures.

### Microscopy and image analysis {#sec4.4.6}

Immunostaining of neurons was performed as described in [@bib36]. For quantifications, identical antibodies solutions were used for all coverslips from the same experiment. For the co-localization analysis, neurons were silenced with APV and CNQX for 10 minutes, in order to minimize the effect of the ongoing activity on the variance between synapses and then stimulated with 200 AP at 40 Hz. Cells were fixed within 30 s after the end of stimulation.

Staining with synaptotagmin 1 antibody (Syt1 Ab uptake) was performed by incubating the cells with fluorescently-labeled primary antibody dissolved in extracellular solution, containing 119 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM glucose, and 25 mM HEPES, pH 7.4 for 30 min at 37°C ([@bib36]) before fixation. For the imaging with CypHer5E-labeled anti-synaptotagmin1 antibody, cells were incubated with the antibody diluted in a buffer containing 120 mM NaCl, 5 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 10 mM glucose, and 18 mM NaHCO3, pH 7.4 for 2-3 hours at 37°C prior imaging.

Epifluorescence images were acquired on a Zeiss Axio Imager A2 microscope with Cool Snap EZ camera (Visitron Systems) controlled by VisiView (Visitron Systems GmbH) software.

Confocal images in [Figure S3](#mmc1){ref-type="supplementary-material"}A were acquired on a Leica SP5 confocal microscope. The format of the images was 2048x2048 pixels display resolution, 8 bit dynamic range, for acquisition 63x objective, NA 1.40 and 2x optical zoom were used, which results in a voxel size of approximately 50 nm.

Dual-color STED images (1024x1024 pixels display resolution, 8 bit dynamic range) were acquired on a Leica TCS SP8-3X gated STED microscope using a HC APO CS2 100x objective, NA 1.40, and 5x optical zoom, corresponding to a voxel size of approximately 23 nm. 16 times line averaging was applied on frames acquired at a scan speed 600 Hz. The built-in pulsed white light laser of the setup was used to excite Abberior STAR 580 and Atto 647N at 561 nm and 650 nm, respectively. The detection was done at 580-620 nm for Abberior STAR 580 and 660-730 nm for Atto647N. Both dyes were depleted using a pulsed 775 nm depletion laser. Time-gated detection of 0.5-1 ns to 6 ns was set for both STED channels. All raw data were subsequently deconvolved using the calculated point spread function (PSF) of the system and the Classic Maximum Likelihood Estimation (CMLE) algorithm with Huygens Professional (SVI,15.10.1). In brief, after an automatic background correction, the signal to noise ratio was set to 15 and the optimized iteration mode of the CMLE was run until a quality threshold of 0.05 was reached. The deconvolved datasets were corrected for a chromatic aberration in z, using the Chromatic Aberration Corrector (CAC) in Huygens.

The co-localization analysis was performed on the deconvolved STED stacks using Imaris 8.3 (Bitplane, Oxford Instruments). To detect punctate staining as spots Imaris spot detection algorithm was applied as follows: the sensitivity for the detection of the spots in each channel was determined by an automatically generated threshold and the spots diameter was set to 0.06 μm. The distances between the spots in the two channels were measured using a customized version of the Imaris XTension Spots Colocalize, which determines the co-localization between the spots within a user-defined distance (1 μm) and bins the data into several bins with equal width (100 nm).

For quantifications, the same detector settings were used for all coverslips quantified in one experiment. From each culture, images from at least two different coverslips were acquired and quantified to minimize experimental variability. The nuclear fluorescence was assessed as established before ([@bib26]). ImageJ (NIH) and OpenView software ([@bib58]) were used for quantitative immunofluorescence analysis. After removing the background by threshold subtraction in ImageJ, synaptic puncta were defined with OpenView software by setting rectangular regions of interest (ROI) with identical dimensions around local intensity maxima in the channel with staining for synapsin or any of the other synaptic markers that were used (GluA, homer1, synaptophysin, SV2B). Mean immunofluorescence (IF) intensities were measured in the synaptic ROIs in all corresponding channels using the same software and normalized to the mean IF intensities of the control group for each of the experiments. The number of synapses per unit of dendrite length was determined as follows: First synapsin puncta along 30 μm of proximal dendrite, was detected using Find Maxima function in ImageJ, by setting the same noise tolerance to all images quantified in one experiment; Mean IF intensities of GluA were measured in circular ROIs set around the local intensity maxima in the image with synapsin staining; The number of GluA puncta co-localizing with synapsin was calculated by applying an identical intensity threshold for GluA detection between the different conditions within an experiment.

### pHluorin imaging and analysis {#sec4.4.7}

The pHluorin imaging was performed with hippocampal cultures DIV16 to 20, transduced with lentiviral particles on the day of plating.

The coverslips were removed from the cell culture plates and mounted in an imaging chamber (Warner instruments), supplied with a pair of platinum wire electrodes, 1 cm apart, for electrical stimulation. The imaging was performed at 26°C in extracellular solution, containing 119 mM NaCl, 2.5 mM KCl, 25 mM HEPES pH7.4, 30 mM glucose, 2 mM MgCl2 and 2 mM CaCl2, 10 μM 6-cyano-7‐nitroquinoxaline-2,3-dione disodium (CNQX, Tocris) and 50 μM d-(-)-2‐amino-5‐phosphonopentanoic acid (APV, Tocris), on inverted microscope (Observer. D1; Zeiss-as described above) equipped with an EMCCD camera (Evolve 512; Photometrics) controlled by MetaMorph Imaging (MDS Analytical Technologies) and VisiView (Visitron Systems GmbH) software, using 63x objective. EGFP ET filter set (exciter 470/40, emitter 525/50, dichroic 495 LP, Chroma Technology Corp.) and Cy5 ET filter set (exciter 620/60, emitter 700/75, dichroic 660 LP, Chroma Technology Corp.) were used for imaging of the pHluorin and CypHer5E, respectively. Cultures were stimulated with a train of 40 or 200 action potentials (1 ms, constant voltage pulses) at 5, 20 or 40 Hz using S48 stimulator (GRASS Technologies). The alkaline trapping method was used for quantification of the recycling vesicle pools. In brief, the stimulation of sypHy expressing neurons was done in presence of bafilomycin A1 (1 μM, Merck/Millipore), a specific inhibitor of the vesicular V-type ATPase. Exocytosis of RRP was triggered by delivering of 40 AP at 20 Hz. Following a 2 min break after the end of the first train of stimuli TRP was released by stimulation with 200 AP at 20 Hz. The relative sizes of RRP and TRP were determined as fractions of the total sypHy-expressing pool measured after addition of alkaline imaging buffer (60 mM NaCl in the extracellular solution was replaced with 60 mM NH~4~Cl). Fluorescent images were acquired at 1 Hz ([Figure 1](#fig1){ref-type="fig"}I) and 10 Hz ([Figures 1](#fig1){ref-type="fig"}F, 1J, 1K, [4](#fig4){ref-type="fig"}E, [6](#fig6){ref-type="fig"}A--6D, [S2](#mmc1){ref-type="supplementary-material"}C, S2G, and [S4](#mmc1){ref-type="supplementary-material"}). Imaging of hippocampal neurons transfected with syp mOrange2 ([Figure 4](#fig4){ref-type="fig"}C) was performed in a modified extracellular solution (136-mM NaCl, 2.5 mM KCl, 2 mM CaCl~2~, 1.3 mM MgCl~2~, 10 mM glucose, and 10 mM HEPES, 10 μM CNQX, 50 μM APV, pH 7.4) on inverted Zeiss Axio Observer.Z1 epifluorescence microscope, equipped with Zeiss AxioCam 506 camera controlled by ZEISS ZEN 2 software, using EC Plan-Neofluar 40x oil immersion objective (NA 1.3) and a DsRED filter set (exciter 538-562, beam splitter 570, emitter 570-640). Cultures were stimulated with a train of 200 AP delivered at 20 Hz (100 mA, 1 ms pulse width) and fluorescent images were acquired at 0.5 Hz. Synaptic puncta responding to stimulation were identified by subtracting an average of the first several frames of the baseline from an average of several frames at the end of stimulation. The mean IF intensities were measured in ROIs with an identical size, placed automatically over each responding synapse using a self-written macro in ImageJ. The data traces were determined after removing the background by threshold subtraction and correction for bleaching, calculated from the bleaching of unresponsive boutons from the same coverslip. The half times for endocytosis (t1/2) were determined by applying a single exponential fit to the decay phases of the data traces using GraphPad Prism5 and the following equation: Ft = Fstim^∗^exp(-t/tau), t1/2 = ln(2)^∗^tau, where Fstim is the fluorescence intensity at the end of stimulation and tau is the time constant for endocytosis.

### Electrophysiology {#sec4.4.7.1}

Whole-cell voltage clamp recordings were performed between 14 and 18 days *in vitro* (DIV) in autaptic neurons at room temperature. Ionic currents were acquired using a Digidata 1440A digitizer and a Multiclamp 700B amplifier under the control of Clampex X software (Axon instrument). Series resistance was set at 70% and only neurons with series resistances below 10 MΩ were selected. Data were recorded at 10 kHz and low-pass filtered at 3 kHz. Borosilicate glass pipettes with a resistance around 3 MΩ were used and filled with an intracellular solution containing (in mM): 136 KCl, 17.8 HEPES, 1 EGTA, 4.6 MgCl~2~, 4 Na~2~ATP, 0.3 Na~2~GTP, 12 phosphocreatine, and 50 U/ml phosphocreatine kinase; 300 mOsm; pH 7.4. Autaptic neurons were continuously perfused with standard extracellular solution composed of (in mM): 140 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 2 CaCl~2~, 4 MgCl~2~; 300 mOsm; pH 7.4. Spontaneous release was measured by recording mEPSC for 30 s at a holding potential of −70 mV in the presence of 3 mM kynurenic acid to detect false positive events and for the equal amount of time in extracellular solution. Data were filtered at 1 kHz and analyzed using template-based miniature event detection algorithms implemented in the AxoGraph X software. Action potential-evoked release EPSCs were elicited by 2 ms somatic depolarization from −70 to 0 mV. To estimate the readily-releasable pool (RRP) size, 500 mM hypertonic sucrose added to standard extracellular solution, was applied for 5 s using a fast-flow system ([@bib46]). For vesicular release probability (Pvr) calculations, the ratio of EPSC charge to RRP charge was determined. Short-term plasticity was examined either by evoking 2 unclamped AP with 25 ms interval (40 Hz) or a train of 50 AP at an interval of 100 ms (10 Hz). All electrophysiological data were analyzed offline using Axograph X (Axograph Scientific).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

All quantitative results are given as means ± standard errors of the mean (SEM) and normalized to the values of control. Statistical analyses were performed with Prism 7 and 8 (GraphPad Software, Inc.). The sample sizes (n numbers) were adjusted based on published studies using similar methodology. n numbers correspond to the number of cells (fixed cell imaging and electrophysiology experiments), individual coverslips (live cell imaging experiments), synaptic profiles (EM data), number of independent immunoprecipitations (IP) or samples from independent animals (WB) and are indicated for each group in the graphs. In the graphs comparisons with the control are indicated above each box and, comparisons between the conditions are given as horizontal bars. The statistical tests were chosen after the distribution of the datasets was explored. The scoring and the statistical tests used to compute the P values and the numeric values of all results are specified in the [Table S3](#mmc2){ref-type="supplementary-material"}. Significance is indicated using asterisks: nsP \> 0.05, ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^ p \< 0.0001.

Data and Code Availability {#sec4.6}
--------------------------

Requests for data and the scripts used for the main steps of the analysis of the pHluorin and STED data should be directed to the Lead Contact Anna Fejtova and will be made available upon reasonable request.
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